6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1m ago	Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
2m ago	State Street : Investment Management makes strategic minority investment in German Digital Wealth Platform getquin
6m ago	Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
12m ago	VYNE Therapeutics : Yarrow Bioscience Investor Presentation
14m ago	SuperBuzz Announces Adoption of Semi-Annual Reporting and CFO Transition

About

1.73CAD-0.01 -0.57%

Closed • Updated at 21:20 GMT+00:00

Market Cap$124.97M

P/E Ratio15.92

Volume14.6K

Beta0.34

RSI43.44

Gross Margin18.02%

Process IndustriesAgricultural Commodities/Milling

Cannara Biotech, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Cannara Completes Acquisition of Medican Organic Inc.

Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec

Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026

Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange

Cannara Biotech Inc. (LOVE) Opens the Market

Community Chat

Ask AI